Literature DB >> 15733089

Delay of myelin formation in arylsulphatase A-deficient mice.

Afshin Yaghootfam1, Volkmar Gieselmann, Matthias Eckhardt.   

Abstract

Metachromatic leukodystrophy (MLD) is a lysosomal storage disorder caused by the deficiency of arylsulphatase A (ASA). This leads to the accumulation of the sphingolipid 3-O-sulphogalactosylceramide (sulphatide) and progressive demyelination in the nervous system of MLD patients. The mechanisms and development of pathology in the disease are still largely unknown. In this study we investigate how the inability to degrade sulphatide affects the formation of myelin in ASA-deficient (ASA-/-) mice. In mice at 2 weeks of age there was a substantial reduction in myelin basic protein (MBP) mRNA and protein. This was confirmed by an immunohistochemical analysis. MBP mRNA and protein, however, reach normal levels at 3 weeks of age. Proteolipid protein (PLP) and MAL mRNA were also reduced in ASA-/- mice at 2 weeks of age; whereas the level of PLP mRNA was normal at 26 weeks of age, MAL mRNA expression remained reduced up to this age. In situ hybridization revealed no significant changes in the number of myelinating oligodendrocytes or oligodendrocyte precursor cells in ASA-/- mice. These results suggest that oligodendrocyte differentiation was normal in ASA-/- mice. No differences were found in the expression of the sulphatide synthesizing enzymes cerebroside sulphotransferase and UDP-galactose : ceramide galactosyltransferase. Our data demonstrate a delay in myelin formation in ASA-/- mice. This raises the possibility that similar alterations in MLD patients may contribute to the pathology of the disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15733089     DOI: 10.1111/j.1460-9568.2005.03891.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  13 in total

1.  Injection of the sciatic nerve with TMEV: a new model for peripheral nerve demyelination.

Authors:  Kristen M Drescher; Steven M Tracy
Journal:  Virology       Date:  2006-10-09       Impact factor: 3.616

2.  Dysfunction of platelet-derived growth factor receptor α (PDGFRα) represses the production of oligodendrocytes from arylsulfatase A-deficient multipotential neural precursor cells.

Authors:  Katarzyna C Pituch; Ana L Moyano; Aurora Lopez-Rosas; Felecia M Marottoli; Guannan Li; Chenqi Hu; Richard van Breemen; Jan E Månsson; Maria I Givogri
Journal:  J Biol Chem       Date:  2015-01-20       Impact factor: 5.157

3.  Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy.

Authors:  Hariharasubramanian Ramakrishnan; Kerstin Khalaj Hedayati; Renate Lüllmann-Rauch; Carsten Wessig; Simon Ngamli Fewou; Helena Maier; Hans-Hilmar Goebel; Volkmar Gieselmann; Matthias Eckhardt
Journal:  J Neurosci       Date:  2007-08-29       Impact factor: 6.167

Review 4.  The role and metabolism of sulfatide in the nervous system.

Authors:  Matthias Eckhardt
Journal:  Mol Neurobiol       Date:  2008-05-09       Impact factor: 5.590

5.  Differential expression of (dihydro)ceramide synthases in mouse brain: oligodendrocyte-specific expression of CerS2/Lass2.

Authors:  Ivonne Becker; Lihua Wang-Eckhardt; Afshin Yaghootfam; Volkmar Gieselmann; Matthias Eckhardt
Journal:  Histochem Cell Biol       Date:  2007-09-28       Impact factor: 4.304

6.  Adult ceramide synthase 2 (CERS2)-deficient mice exhibit myelin sheath defects, cerebellar degeneration, and hepatocarcinomas.

Authors:  Silke Imgrund; Dieter Hartmann; Hany Farwanah; Matthias Eckhardt; Roger Sandhoff; Joachim Degen; Volkmar Gieselmann; Konrad Sandhoff; Klaus Willecke
Journal:  J Biol Chem       Date:  2009-09-30       Impact factor: 5.157

7.  Brain conditioning is instrumental for successful microglia reconstitution following hematopoietic stem cell transplantation.

Authors:  Alessia Capotondo; Rita Milazzo; Letterio Salvatore Politi; Angelo Quattrini; Alessio Palini; Tiziana Plati; Stefania Merella; Alessandro Nonis; Clelia di Serio; Eugenio Montini; Luigi Naldini; Alessandra Biffi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-23       Impact factor: 11.205

8.  Oligodendroglial progenitor cell therapy limits central neurological deficits in mice with metachromatic leukodystrophy.

Authors:  Maria I Givogri; Francesca Galbiati; Stefania Fasano; Stefano Amadio; Laura Perani; Daniela Superchi; Pablo Morana; Ubaldo Del Carro; Sergio Marchesini; Riccardo Brambilla; Lawrence Wrabetz; Ernesto Bongarzone
Journal:  J Neurosci       Date:  2006-03-22       Impact factor: 6.167

Review 9.  Enzyme, cell and gene-based therapies for metachromatic leukodystrophy.

Authors:  C Sevin; P Aubourg; N Cartier
Journal:  J Inherit Metab Dis       Date:  2007-03-08       Impact factor: 4.750

10.  PI(3,5)P2 biosynthesis regulates oligodendrocyte differentiation by intrinsic and extrinsic mechanisms.

Authors:  Yevgeniya A Mironova; Guy M Lenk; Jing-Ping Lin; Seung Joon Lee; Jeffery L Twiss; Ilaria Vaccari; Alessandra Bolino; Leif A Havton; Sang H Min; Charles S Abrams; Peter Shrager; Miriam H Meisler; Roman J Giger
Journal:  Elife       Date:  2016-03-23       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.